Adrenergic pathways and left ventricular remodeling

Keyphrases

• Adrenergic Receptors 100%
• Left Ventricular Remodeling 100%
• Adrenergic Pathway 100%
• Cardiomyocytes 50%
• G Protein 50%
• Signaling Pathway 33%
• Catecholamines 33%
• Hypertrophy 33%
• Transgenic Overexpression 33%
• Pressure Overload Hypertrophy 33%
• Myocardial Contraction 33%
• Overexpression 16%
• Phospholipase C 16%
• Clinical Syndromes 16%
• Cardiomyopathy 16%
• Pharmacologic 16%
• Concentration-dependent 16%
• Myocardial Fibrosis 16%
• Cardiac Hypertrophy 16%
• Concentric Hypertrophy 16%
• Epinephrine and Norepinephrine 16%
• Cardiomyocyte Apoptosis 16%
• Cardiac Function 16%
• Dilated Cardiomyopathy 16%
• Receptor System 16%
• Phenotypic Characteristics 16%
• Ventricular Remodeling 16%
• Pheochromocytoma 16%
• Adenylate Cyclase 16%
• End Organ 16%
• Ventricular Dilation 16%
• Sympathetic Tone 16%
• Cell Size 16%
• PKC Pathway 16%
• Gq Signaling 16%
• Protein Kinase A Pathway 16%
• In Vivo Heart 16%
• Cardiac Insufficiency 16%
• Catecholamine Cardiomyopathy 16%
• Eccentric Hypertrophy 16%
• Cardiac Genes 16%
• Compensated Hypertrophy 16%
• Acute Effects 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Adrenergic Receptor 100%
• Heart Ventricle Remodeling 100%
• Guanine Nucleotide Binding Protein 50%
• Catecholamine 50%
• Myocardial Disease 33%
• Congestive Heart Failure 16%
• Syndrome 16%
• Epinephrine 16%
• Adenylate Cyclase 16%
• Congestive Cardiomyopathy 16%
• Heart Ventricle Hypertrophy 16%
• Cyclic AMP Dependent Protein Kinase 16%
• Heart Muscle Fibrosis 16%
• Noradrenalin 16%
• Pheochromocytoma 16%
• Lecithinase 16%